ICU Medical Market Risk Adjusted Performance
| ICUI Stock | | | USD 127.32 1.47 1.17% |
The Market Risk Adjusted Performance technical lookup provides context for ICU Medical and related instruments. Coverage depends on data availability and normalization;
Equity Screeners provides additional screening context. ICU Medical has a market cap of 3.11 B, operating margin of 4.82%, ROE of 0.04%. Review
Risk vs Return Analysis for broader portfolio context. This suggests a position in ICU Medical inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
For a practical introduction to investing in ICU Stock, check out our
How to Buy ICU Medical guide.
ICU Medical has current Market Risk Adjusted Performance of
-0.1.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.1 | |
| ER[a] | = | Expected return on investing in ICU Medical |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
ICU Medical Market Risk Adjusted Performance Peers Comparison
ICU Market Risk Adjusted Performance Relative To Other Indicators
ICU Medical places
fifth for market risk adjusted performance among direct rivals. It is currently under evaluation for maximum drawdown among direct rivals .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.